Tocilizumab in COVID-19: some clarity amid controversy

Hyperactivation of the immune response, including release of pro-inflammatory cytokines such as interleukin-6 (IL-6), might play a key role in the pathophysiology of severe illness from COVID-19.

  • Del Valle DM
  • Kim-Schulze S
  • Huang HH
  • et al.
An inflammatory cytokine signature predicts COVID-19 severity and survival.